Carticept Medical
Founded Year
2005Stage
Series C | AliveTotal Raised
$50.24MLast Raised
$10M | 12 yrs agoAbout Carticept Medical
Carticept Medical is a medical device-developing company. It provides solutions for patients with osteoarthritis and cartilage damage. It offers products to address the shortcomings of the current conservative and surgical treatment options for osteoarthritis and cartilage injuries such as ultrasound products, computer-controlled infusion systems, and a medical device to replace and repair worn and damaged cartilage. Carticept Medical was formerly known as Windward Medical. The company was founded in 2005 and is based in Alpharetta, Georgia.
Loading...
Loading...
Carticept Medical Patents
Carticept Medical has filed 15 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/22/2011 | 7/26/2016 | Fluid dynamics, Skeletal system, Gastropod anatomy, Lithics, Sauropods | Grant |
Application Date | 8/22/2011 |
|---|---|
Grant Date | 7/26/2016 |
Title | |
Related Topics | Fluid dynamics, Skeletal system, Gastropod anatomy, Lithics, Sauropods |
Status | Grant |
Latest Carticept Medical News
Jul 16, 2013
VentureWire , (c) 2013 Dow Jones & Company, Inc. (c) 2013 Dow Jones & Company, Inc. Cartiva Inc., a spinoff from venture-backed Carticept Medical Inc ., said it has raised a $4.3 million financing led by New Enterprise Associates . Cartiva, based in Alpharetta, Ga., last year completed enrollment in a prospective randomized clinical trial for osteoarthritis of the first metatarsophalangeal joint of the great toe. The 236-patient study was designed to determine the safety and efficacy of its synthetic cartilage implant in comparison to fusion, the standard of care.... Document DJFVW00020130715e97fs6uou
Carticept Medical Frequently Asked Questions (FAQ)
When was Carticept Medical founded?
Carticept Medical was founded in 2005.
Where is Carticept Medical's headquarters?
Carticept Medical's headquarters is located at 6120 Windward Parkway, Alpharetta.
What is Carticept Medical's latest funding round?
Carticept Medical's latest funding round is Series C.
How much did Carticept Medical raise?
Carticept Medical raised a total of $50.24M.
Who are the investors of Carticept Medical?
Investors of Carticept Medical include New Enterprise Associates, Domain Associates, LumenVu, Frazier Healthcare Partners and Qualifying Therapeutic Discovery Project.
Who are Carticept Medical's competitors?
Competitors of Carticept Medical include Cardiva Medical, Sonivate Medical, Valtech Cardio, Magneceutical Health, Penumbra and 7 more.
Loading...
Compare Carticept Medical to Competitors
Fairway Medical Technologies is an FDA registered medical device, design, development and manufacturing company. It invents, innovates, and invests in medical technologies. In addition to supporting early stage startups with technology and business development, Fairway helps them obtain SBIR (Small Business Innovative Research) and other commercialization grants. As of 2009, Fairway and its Portfolio Companies have received over $15 Million in grants from the National Institute of Health (NIH) and the State of Texas' Emerging Technology Fund (ETF).
Mercator MedSystems is a medical technology company that focuses on the treatment of peripheral artery disease. The company offers catheter-guided, microfluid injection systems for site-specific, non-systemic delivery of therapeutic agents directly across any blood vessel, providing efficient and targeted treatment for vascular diseases. The technology also finds application in the treatment of hypertension, oncology, and regenerative medicine. Mercator MedSystems was formerly known as EndoBionics. It was founded in 1999 and is based in Emeryville, California.
Acorn Cardiovascular is a medical device company pursuing treatments for patients with heart failure. Acorn
ThermalTherapeutic Systems is currently developing a portable next-generation perfusion device for international distribution.
ADVOS, developed by ADVITOS, is a company focused on the healthcare sector, specifically in the field of intensive care treatment. The company's main offering is a certified innovative treatment for multi-organ failure in intensive care units, which simultaneously supports the kidney, liver, and lung functions, and also regulates the pH of the blood. The primary customers of ADVOS are likely to be healthcare providers in the intensive care industry. ADVOS was formerly known as Hepa Wash. It was founded in 2004 and is based in Munich, Germany.
Nexeon MedSystems is committed to improving lives through the development of therapies for people with cardiovascular disease. With proven medical device research and development talent, a strong intellectual property portfolio and the leadership of a veteran interventional cardiologist, Nexeon has created an pipeline of products for unmet clinical needs.
Loading...